In normal aging, increased synaptic activity may drive PSA-NCAM upregulation, while in AD, chronic excitotoxicity, Aβ burden, and neuroinflammation likely accelerate its degradation or downregulate its synthesis. The gene discussed is NCAM1; the disease is Alzheimer disease.